Allena Pharmaceuticals, Inc. - FORM 10-Q - EX-32.1 - EX-32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFF - November 7, 2018

Attached files

file filename
EX-31.2 - EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RU - Allena Pharmaceuticals, Inc.alna-ex312_7.htm
EX-31.1 - EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RU - Allena Pharmaceuticals, Inc.alna-ex311_8.htm
EX-10.10 - EX-10.10 COMMERCIAL LEASE WITH CUMMINGS PROPERTIES LLC - Allena Pharmaceuticals, Inc.alna-ex1010_26.htm
10-Q - 10-Q - 093018 - Allena Pharmaceuticals, Inc.alna-10q_20180930.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Allena Pharmaceuticals, Inc. (the “Company”) for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to his knowledge:

 

1)

the Report which this statement accompanies fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

November 7, 2018

By:

/s/ Alexey Margolin

 

 

Alexey Margolin

 

 

Chief Executive Officer and Director

(Principal Executive Officer)

 

 

 

November 7, 2018

By:

/s/ Edward Wholihan

 

 

Edward Wholihan

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

Allena Pharmaceuticals, Inc. Reports